fbpx
May 1, 2025

New cancer clinical trial: Apatinib Combine With Platinum‐Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Published on: June 25, 2017 at 12:00PM
Conditions:   Lung Cancer;   Non Small Cell Lung Cancer;   Combination Chemotherapy;   Apatinib
Interventions:   Drug: Apatinib;   Drug: AP or AC;   Drug: Apatinib 250mg;   Drug: Apatinib 500mg;   Drug: Apatinib 750mg
Sponsors:   West China Hospital;   Jiangsu HengRui Medicine Co., Ltd.
Recruiting – verified June 2017
http://ift.tt/2tkaSz7

%d bloggers like this: